Erythromycin in Septic Patients: Immunomodulatory Role and Clinical Impact

Clinical trial NCT04665089 · COMPLETED

Trial details

NCT number: NCT04665089
Sponsor: Tunis University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sepsis Septic Shock Immunoinflammatory Response

Start date: 2022-01-01
Primary completion: 2023-01-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.